}}</ref><ref>[https://bitnest.netfirms.com/external.php?id=%2518%253A3%25172%251BE%2524K%255BG%2521%2524%257D%2504%2504V Hansen, M. Design and Synthesis of Selective Serotonin Receptor Agonists for Positron Emission Tomography Imaging of the Brain. PhD Thesis, University of Copenhagen, 2011.]</ref> 25D-NBOMe has been sold as a street drug since 2010 and produces similar effects in humans to related compounds such as [[25I-NBOMe]] and [[25C-NBOMe]].<ref>{{cite journal|last=Casale|first=John F.|author2=Hays, Patrick A.|title=Characterization of Eleven 2,5-Dimethoxy-N-(2-methoxybenzyl)phenethylamine (NBOMe) Derivatives and Differentiation from their  3- and 4-Methoxybenzyl Analogues - Part I|journal=Microgram Journal|year=2012|volume=9|issue=2|pages=84â€“109|url=https://www.dea.gov/pr/microgram-journals/2012/mj9_84-109.pdf|accessdate=14 January 2014}}</ref> It was banned as a [[Temporary Class Drug]] in the UK on 10 June 2013 after concerns about its recreational use.<ref name='ACMD report'>{{cite web | url = https://www.gov.uk/government/publications/temporary-class-drug-order-report-on-benzofury-and-nbome-compounds | title = Temporary class drug order report on 5-6APB and NBOMe compounds | accessdate = 2013-07-10 | date = 4 Jun 2013 | publisher = UK Home Office}}</ref>
